IGF1 and schizophrenia: Conversely, in the subgroup analysis, European patients were found to have significantly lower peripheral IGF‐1 levels after antipsychotic treatment compared to baseline, but peripheral IGF‐1 levels were not significantly different between antipsychotic‐treated schizophrenia patients and healthy controls in this population.